Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Hohenstein

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Clinical Research in Cardiology Supplements|February 10, 2017
Lipoprotein(a) in nephrological patientsBernd Hohenstein
Deutsche Medizinische Wochenschrift (1946)|February 19, 2020
[C3 glomerulopathy and MPGN - current classification]Bernd Hohenstein
Kidney International|December 23, 2016
Peritubular capillaries: an important piece of the puzzleBernd Hohenstein, Christian Hugo
Deutsche Medizinische Wochenschrift (1946)|November 10, 2025
[AI Application in Nephrological Diagnostics]Bernd Hohenstein, Tim Binder, Rafael Kramann
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 3, 2020
With reasonable doubt: Plasma exchange in PEXIVASBernd Hohenstein, Volker Schettler, Kirsten de Groot
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritisBernd Hohenstein, Christoph Daniel, Sandra Wittmann, et al.
Atherosclerosis. Supplements|May 5, 2015
Immunoadsorption with regenerating systems in neurological disorders --A single center experienceBernd Hohenstein, Jens Passauer, Tjalf Ziemssen, et al.
American Journal of Physiology. Renal Physiology|September 4, 2009
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activationChristoph Daniel, Andrea Wagner, Bernd Hohenstein, et al.
Atherosclerosis. Supplements|November 4, 2017
Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulinsSergey Tselmin, Ulrich Julius, Stefan R Bornstein, et al.
Atherosclerosis. Supplements|November 4, 2017
How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? - Estimates form a large single centerBernd Hohenstein, Sergey Tselmin, Stefan R Bornstein, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Clinical Research in Cardiology Supplements|February 10, 2017
Lipoprotein(a) in nephrological patientsBernd Hohenstein
Deutsche Medizinische Wochenschrift (1946)|February 19, 2020
[C3 glomerulopathy and MPGN - current classification]Bernd Hohenstein
Kidney International|December 23, 2016
Peritubular capillaries: an important piece of the puzzleBernd Hohenstein, Christian Hugo
Deutsche Medizinische Wochenschrift (1946)|November 10, 2025
[AI Application in Nephrological Diagnostics]Bernd Hohenstein, Tim Binder, Rafael Kramann
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 3, 2020
With reasonable doubt: Plasma exchange in PEXIVASBernd Hohenstein, Volker Schettler, Kirsten de Groot
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2008
PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritisBernd Hohenstein, Christoph Daniel, Sandra Wittmann, et al.
Atherosclerosis. Supplements|May 5, 2015
Immunoadsorption with regenerating systems in neurological disorders --A single center experienceBernd Hohenstein, Jens Passauer, Tjalf Ziemssen, et al.
American Journal of Physiology. Renal Physiology|September 4, 2009
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activationChristoph Daniel, Andrea Wagner, Bernd Hohenstein, et al.
Atherosclerosis. Supplements|November 4, 2017
Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulinsSergey Tselmin, Ulrich Julius, Stefan R Bornstein, et al.
Atherosclerosis. Supplements|November 4, 2017
How effectively will PCSK9 inhibitors allow retrieval of freedom from apheresis in cardiovascular high risk patients? - Estimates form a large single centerBernd Hohenstein, Sergey Tselmin, Stefan R Bornstein, et al.
Pageof 7